Key result
Older age linked to ~54% faster kidney function decline, an effect magnified by hypertension.
Why the study?
Aging is linked to kidney function decline, but the impact of age and its interplay with chronic kidney disease risk factors, mainly hypertension, in the general population needed evaluation.
Does hypertension accelerate age-related kidney function decline in the general population?
Cohort (n=4,163)
No
Does hypertension accelerate age-related kidney function decline in the general population?
Hypertension is a major pathological factor that significantly aggravates the age-related physiological decline in kidney function in the general population.
Hypertension may accelerate age-related kidney decline in older adults; hypothesis-generating for targeted trials before practice change.
Background Aging is associated with a physiological decline in kidney function (KFD). In this study, we aimed to describe the impact of age on the rate of KFD and its interplay with risk factors for chronic kidney disease (CKD), considering mainly hypertension (HT), in the general population. Materials and methods Participants of European descent, aged 35–75, were recruited from a populational cohort in Lausanne, Switzerland. Participants with a 10 year follow-up were selected. KFD was defined as the difference in estimated glomerular filtration rate (eGFR) between baseline and follow-up, divided by the observation period. Multivariate linear regressions were used with KFD as the outcome and age as the main predictor. HT was tested as a modifying factor. Results We included 4,163 participants with mean age 52.2 ± 10.4, 44.7% men, 31.9% HT, and 5.0% diabetics. Mean baseline eGFR was 85.9 ± 14.6 ml/min/1.73 m 2 . Mean KFD was –0.49 ± 1.08 ml/min/1.73 m 2 per year with 70% of participants decreasing their eGFR during follow-up. The relationship between age and KFD was non-linear and age was divided in tertiles. Old participants had faster rates of KFD as compared to young and middle-age participants ( p < 0.001). A significant interaction was found between age and HT on KFD prediction ( p < 0.001). In HT participants, KFD was significantly different across tertiles of age ( p < 0.001). On contrary, KFD was not different across tertiles of age in non-HT participants. Conclusion A physiological KFD is present over time in the general population. Age contributes non-linearly to the rate of this decline with older subjects declining the fastest. The presence of HT is a major contributing factor in this setting as KFD worsened with age only in hypertensive participants. Thus, HT represents an important pathological factor aggravating the age-related physiological decline in eGFR in the general population.
No takes yet. Share an insight, caveat, or question.
Jaques et al. (2022) conducted a cohort in Kidney function decline (n=4,163). Older age vs. Younger age was evaluated on Kidney function decline (ml/min/1.73 m2 per year) (95% CI -0.85 to -0.34, p=<0.001). Older age was associated with a faster kidney function decline of -0.60 ml/min/1.73 m2 per year compared to -0.39 in the youngest participants, an effect significantly magnified by hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: